Insider trade

Annovis Bio (ANVS): Director bought ~$5M

Michael B Hoffman, Director at Annovis Bio, bought ~$5M of Annovis Bio shares.

~$5M
Approx. value · 5M sh @ $1.00: 8.36M
Holds after · shares reported

Traded: Nov 6, 2026
Filed: Nov 6, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

Oct 15, 20265% stakeEmpery Asset Management, LP reported a passive stake (13G) of 5.0%
Oct 29, 2026Company filing · Form 8-K · Listing notice, Reg FDReceived a notice from its stock exchange, and shared information with investors“On October 29, 2026, Annovis Bio, Inc. (the “Company”) received notice (the “Notice”) from the New York Stock Exchange (the “NYSE”) that it is no longer in compliance with the NYSE continued listing standards set forth in Section 802.01B of the NYSE’s Listed Company Manual due to the fact that the Company’s average market capitalization over a consecutive 30 trading-day period was less than $50 million and, at the…”
Nov 3, 2026Company filing · Form 8-K · Bylaws or charter, Shareholder voteChanged its bylaws, charter or fiscal year, and held a shareholder vote
Nov 4, 2026Company filing · Form 8-K · Results, Reg FDReported its results, and shared information with investors (and 1 more item)
Nov 5, 2026Company filing · Form 8-K · Material agreement, Reg FDSigned an important agreement, and shared information with investors
Nov 6, 2026 · this disclosureInsider · Largest insider buy since 2020Director purchased ~$5M of ANVS shares in the open market

What came next

Nov 13, 2026Company filing · Form 8-K · ResultsReported its results

View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Annovis Bio

For Annovis Bio, OQRO holds 1 insider filing (SEC Form 4 or Form 144) and 1 fund holdings report (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its ANVS page.

Other recent filings by Michael B Hoffman, Director

The full history of Michael B Hoffman, Director is on the profile page.

How this filing works

Explore the data

Other disclosures at Annovis Bio

Everything OQRO holds on this company is on its ANVS page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data